Renal

Question 1

Avodart

Dutasteride (PO)

Answer 1

Pharmacologic category: 5-alpha-reductase inhibitor
Common indication: BPH
Key side effects: oropharyngeal irritation (dutasteride only), decreased libido, impotence
Other Notes: swallow whole (dutasteride only); women who are pregnant or of child-bearing age should not touch

Question 2

Proscar, Propecia

finasteride (PO)

Answer 2

Pharmacologic category: 5-alpha reductase inhibitor
Common indication: BPH, male pattern baldness
Key side effects: decreased libido, impotence
Other Notes: women who are pregnant or of child-bearing age should not touch

Question 3

Cardura

Doxazosin (PO)

Answer 3

Pharmacologic category: alpha1 blocker
Common indication: BPH, HTN
Key Side effects: dizziness, orthostatic hypotension, priapism (rare), intraoperative floppy iris syndrome (rare)

Question 4

Hytrin

Terazosin (PO)

Answer 4

Pharmacologic category: alpha1 blocker
Common indication: BPH, HTN
Key side effects: dizziness, orthostatic hypotension, priapism (rare), intraoperative floppy iris syndrome (rare)

Question 5

Flomax

Tamsulosin (PO)

Answer 5

Pharmacologic category: alpha1a blocker
Common indication: BPH
Key side effects: dizziness, orthostatic hypotension, priapism (rare), intraoperative floppy iris syndrome (rare)
Other Notes: take 30 minutes after the same meal daily

Question 6

Toviaz

Fesoterodine (PO)

Answer 6

Pharmacologic category: anticholinergic
Common indication: overactive bladder
Key side effects: xerostomia, constipation, angioedema (rare)
Other Notes: CI in uncontrolled narrow-angle glaucoma

Question 7

Vesicare

Solifenacin (PO)

Answer 7

Pharmacologic category: anticholinergic
Common indication: overactive bladder
Key side effects: xerostomia, constipation, angioedema (rare)
Other Notes: CI in uncontrolled narrow-angle glaucoma

Question 8

Detrol, Detrol LA

Tolterodine (PO)

Answer 8

Pharmacologic category: anticholinergic
Common indication: overactive bladder
Key side effects: xerostomia, constipation, angioedema (rare)
Other Notes: CI in uncontrolled narrow-angle glaucoma

Question 9

Ditropan, Ditropan XL

Oxybutynin (PO)

Answer 9

Pharmacologic category: anticholinergic, urinary antispasmodic agent
Common indication: overactive bladder
Key side effects: xerostomia, constipation, dizziness, drowsiness, angioedema (rare)
Other Notes: CI in uncontrolled narrow-angle glaucoma

Question 10

Azo Urinary Pain Relief, Pyridium

Phenazopyridine (PO)

Answer 10

Pharmacologic category: urinary analgesic
Common indication: symptomatic relief of dysuria
Key side effects: stomach cramps, headache, dizziness
Other notes: may change bodily fluids red/orange

Question 11

Calcium gluconate (IV)

Answer 11

Pharmacologic category: electrolyte supplement
Common indication: hypocalcemia
Key side effects: hypercalcemia, arrhythmia
Other notes: precipitation occurs with phosphate; do not administer IM; vesicant

Question 12

Magnesium sulfate (IV, IM)

Answer 12

Pharmacologic category: electrolyte supplement
Common indication: hypomagnesemia, pre-eclampsia
Key side effects: cardiac arrest (with rapid undiluted IV infusion)
Other Notes: ISMP-high alert medication: dilute before infusion

Question 13

PO: K-Tab, Klor-Con, Micro-K

Potassium chloride (PO, IV)

Answer 13

Pharmacologic category: electrolyte supplement
Common indication: hypokalemia
Key side effects (IV): hyperkalemia, cardiac arrest with rapid undiluted infusion
Key side effects (PO): hyperkalemia, abdominal discomfort/pain, diarrhea, flatulence, nausea, vomiting
Other Notes: ISMP-high alert medication; dilute before infusion; do not administer IV push; vesicant; tablets with wax coating may appear in stool

Question 14

Potassium phosphate (IV)

Answer 14

Pharmacologic category: electrolyte supplement
Common indication: hypokalemia
Key side effects: hyperkalemia, hyperphosphatemia, cardiac arrest (with rapid undiluted IV infusion)
Other Notes: ISMP-high alert medication; must dilute before infusion; precipitation occurs with calcium; vesicant

Question 15

Ergocalciferol (vitamin D2) (PO)

Answer 15

Pharmacologic category: fat-soluble vitamin
Common indication: dietary supplement, hypoparathyroidism
Key side effects: hypervitaminosis D
Other Notes: CI with hypercalcemia

Question 16

Rocaltrol

Calcitriol (PO)

Answer 16

Pharmacologic category: vitamin D analog
Common indication: secondary hyperparathyroidism
Key side effects: hypercalcemia, hyperphosphatemia

Question 17

Albuminar, Plasbumin

Albumin, 5% or 25% (IV)

Answer 17

Pharmacologic category: colloid
Common indication: 5%: hypovolemia; 25%: large volume paracentesis
Key side effects: hypervolemia

Question 18

Normal saline

0.9% sodium chloride (IV)

Answer 18

Pharmacologic category: crystalloid
Common indication: hypovolemia, carrier fluid
Key side effects: hypervolemia, non-anion gap metabolic acidosis

Question 19

LR

Lactated ringers (IV)

Answer 19

Pharmacologic category: crystalloid
Common indication: hypovolemia
Key side effects: hypervolemia

Question 20

D5W

5% dextrose in water (IV)

Answer 20

Pharmacologic category: crystalloid
Common indication: carrier fluid, hypernatremia, hypoglycemia
Key side effects: hyperglycemia, hyponatremia, hypervolemia